EichorEICHOR
Study identifier: NCT03429582 Synced from ClinicalTrials.gov · August 04, 2026
● Completed

Comparison of Cervical CIN II/III Treatment Outcomes With Thermal Ablation Device

Condition: Cervical Intraepithelial Neoplasia  ·  Sponsor: The Cleveland Clinic

PhaseNA
Planned participants1154
Who can joinFemale, 18 Years to no upper limit
Healthy volunteersNo

About this study

The purpose of this academic-industrial partnership will be to compare two thermoablation modalities using devices adapted to low and middle income countries (LMICs) to traditional CO2-based cryotherapy for the treatment of cervical precancer. The investigators will investigate whether the cure rates of cervical intraepithelial neoplasia 2 and more severe diagnoses (CIN2+) with these devices are non-inferior compared to that of conventional cryotherapy. The results of this study will affect other research areas by serving as a springboard to exploring treatment alternatives that are amenable to low-resource settings and thus will reach the most vulnerable populations.

This description comes directly from the study's public registry record.

Talk to the study team

No contact information is available for this study as per the public registry record.

Always discuss trial participation with your own doctor first.

Locations (2)

Peking University Shenzhen HospitalShenzhen, China
Hospital Nacional de la MujerSan Salvador, El Salvador

Follow this study

Save your interest here for when the public record changes — results posted, or the study's status changes. Email alerts for this study aren't switched on yet.

We keep this only about this public record, and never email you without alerts being switched on. Want it removed at any time? Email hello@eichor.com. Never medical advice. By subscribing you agree to our Terms of Use and Privacy Policy.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →